Mortality News and Research

RSS

Correlations found between 'long-COVID' patients and preexisting health conditions

Researchers from the nference (a biotech information firm) in Cambridge, MA, USA, the Mayo Clinic in Rochester, MN, USA, and nference Labs based in Bengaluru, India, recently performed a retrospective analysis of 266 COVID-19 patients.

4 Nov 2020

AI can improve efficiency of radiologists in reading breast cancer screening mammograms

Artificial intelligence can enhance the performance of radiologists in reading breast cancer screening mammograms, according to a study published in Radiology: Artificial Intelligence.

4 Nov 2020

Extreme levels of serum uric acid linked to substantial reduction in patient survival

Extreme values of serum uric acid levels in the blood can markedly reduce a patient's chance of surviving and reduce their lifespans by up to 11 years, according to a new study by researchers at University of Limerick's School of Medicine.

4 Nov 2020

Experts release new guidance for endoscopists on how to assess colorectal lesions

Early identification and removal of cancerous colorectal polyps is critical to preventing the progression of colorectal cancer and improving survival rates.

4 Nov 2020

Most SARS-CoV-2-infected individuals develop durable B cell-mediated immunity

Researchers from the Johns Hopkins University and The Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, USA, investigated the durability of B cell immunity following SARS-CoV-2 infection and recovery in their recent work published on the preprint server medRxiv.

3 Nov 2020

Some of the main osteoporosis treatments could have a protective effect against COVID-19

Some of the principal treatments for osteoporosis, denosumab, zoledronate and calcium, could have a protective effect against COVID-19 in patients who take them, specifically a 30 to 40% reduction in the rate of infection, according to the results of a joint study by Hospital del Mar, the Hospital del Mar Medical Research Institute (IMIM), Pompeu Fabra University and the Pere Virgili Health Park.

3 Nov 2020

Primary care for acute health conditions declined dramatically since UK lockdown

Researchers have conducted a study showing substantial reductions in the number of people attending primary care services for key physical and mental health conditions in the UK since lockdown was introduced on March 23rd this year.

3 Nov 2020

Study estimates the proportion of COVID-19 deaths due to air pollution

Long-term exposure to air pollution generated by human activity is linked to about 27 per cent of COVID-19-related deaths in East Asia and 15 per cent mortality in South Asia and worldwide. These deaths could be largely prevented by adopting air quality regulations, says a new study.

3 Nov 2020

How COVID death counts become the stuff of conspiracy theories

In the waning days of the campaign, President Donald Trump complained repeatedly about how the United States tracks the number of people who have died from COVID-19, claiming, "This country and its reporting systems are just not doing it right."

2 Nov 2020

More than 45,000 cardiac procedures were missed due to Covid-19 lockdown

The Covid-19 lockdown led to more than 45,000 cardiac procedures being missed this year, which could have a long-term impact on mortality rates as healthcare providers work to catch up.

2 Nov 2020

Research finds increase in risky sexual behavior and STIs despite COVID-19 pandemic

New research launched at the 29th EADV Congress, EADV Virtual, has found that despite the COVID-19 (SARS-CoV-2) lockdown restrictions, diagnosis of sexually transmitted infections (STIs), including gonorrhoea, secondary syphilis and mycoplasma genitalium (MG), have increased.

2 Nov 2020

Researchers develop a unique method of identifying early signs of acute kidney injury

Researchers at the University of Liverpool have identified a unique method of identifying the early signs of a potentially serious condition known as Acute Kidney Injury (AKI).

2 Nov 2020

Ethacridine blocks SARS-CoV-2 with a distinct mode of action

Now, researchers from the University of California, San Francisco, and Stanford University, California, USA, reported a safe and potent antiseptic for use in humans named ethacridine, which effectively inhibits SARS-CoV-2 even at very low concentrations of EC50 ~ 0.08 µM. Their work has is published on the preprint server bioRxiv*.

1 Nov 2020

Glucose-lowering drugs have neutral effect on mortality, adverse outcomes in COVID-19 patients with type 2 diabetes

In a preprint paper, "Impact of Glucose-Lowering Drugs on Mortality and Other Adverse Outcomes in Patients with Type 2 Diabetes Admitted for COVID-19," researchers conclude a neutral effect on mortality and other adverse outcomes.

30 Oct 2020

Study identifies new cause of inflammation in people living with HIV

While current antiretroviral treatments for HIV are highly effective, data has shown that people living with HIV appear to experience accelerated aging and have shorter lifespans - by up to five to 10 years - compared to people without HIV.

30 Oct 2020

University of Illinois Urbana-Champaign professor wins $4.5 million for breast cancer research and therapy

University of Illinois Urbana-Champaign Professor of Molecular and Integrative Physiology Erik Nelson has won a $4.5M Era of Hope Scholar Award from the United States Department of Defense (DoD) Breast Cancer Research Program (BCRP).

30 Oct 2020

Penn State and Stanford University collaborate to develop two-hour sepsis test

One in three people who die in U.S. hospitals have sepsis, the body's extreme response to infection that can lead to multiple organ failure. Diagnosis can take up to five days, but death may take only hours from the initial onset of sepsis.

30 Oct 2020

Scientists receive prestigious award for research on rural America

A research team of 39 investigators from 28 colleges and universities from across the United States has been recognized by the Association of Public and Land-Grant Universities and the United States Department of Agriculture with its National Excellence in Multistate Research Award.

30 Oct 2020

SARS-CoV-2 viroporin triggers NLRP3 inflammasome causing a severe inflammatory response

Now, a team of researchers at the University of Florida report that the SARS-CoV-2 viroporin triggers the NLR Family Pyrin Domain Containing 3 (NLRP3) inflammasome, which is responsible for the inflammatory pathology in severely ill COVID-19 patients.

30 Oct 2020

Symptoms and outcomes of 3.32 million people tested for SARS-CoV-2

A recent study published on the preprint server medRxiv* in October 2020 shows the need for large-scale studies on the clinical characteristics and outcomes of COVID-19 at the national and international scale. This is essential to shape interventions and optimize the use of resources to contain and manage a second wave of the pandemic.

30 Oct 2020

Mortality News and Research

Correlations found between 'long-COVID' patients and preexisting health conditions

AI can improve efficiency of radiologists in reading breast cancer screening mammograms

Extreme levels of serum uric acid linked to substantial reduction in patient survival

Experts release new guidance for endoscopists on how to assess colorectal lesions

Most SARS-CoV-2-infected individuals develop durable B cell-mediated immunity

Some of the main osteoporosis treatments could have a protective effect against COVID-19

Primary care for acute health conditions declined dramatically since UK lockdown

Study estimates the proportion of COVID-19 deaths due to air pollution

How COVID death counts become the stuff of conspiracy theories

More than 45,000 cardiac procedures were missed due to Covid-19 lockdown

Research finds increase in risky sexual behavior and STIs despite COVID-19 pandemic

Researchers develop a unique method of identifying early signs of acute kidney injury

Ethacridine blocks SARS-CoV-2 with a distinct mode of action

Glucose-lowering drugs have neutral effect on mortality, adverse outcomes in COVID-19 patients with type 2 diabetes

Study identifies new cause of inflammation in people living with HIV

University of Illinois Urbana-Champaign professor wins $4.5 million for breast cancer research and therapy

Penn State and Stanford University collaborate to develop two-hour sepsis test

Scientists receive prestigious award for research on rural America

SARS-CoV-2 viroporin triggers NLRP3 inflammasome causing a severe inflammatory response

Symptoms and outcomes of 3.32 million people tested for SARS-CoV-2

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Exploring the G:Box and for high-quality imaging

Latest News